Claudio Montuori

发表

Efficacy of Biologics on Refractory Eosinophilic Otitis Media Associated with Bronchial Asthma or Severe Uncontrolled CRSwNP

G. Paludetti, J. Galli, E. Cantone, 2022, Journal of clinical medicine.

Mepolizumab Improves Outcomes of Chronic Rhinosinusitis with Nasal Polyps in Severe Asthmatic Patients: A Multicentric Real-Life Study

M. Bonini, A. Spanevello, D. Visca, 2022, Journal of personalized medicine.

Proposal for a Structured Outpatient Clinic for Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps in the First Year of Treatment

L. Pignataro, S. Ferrucci, S. Torretta, 2022, Journal of personalized medicine.

Sinonasal Biomarkers Defining Type 2-High and Type 2-Low Inflammation in Chronic Rhinosinusitis with Nasal Polyps

J. Galli, E. de Corso, C. Caruso, 2022, Journal of personalized medicine.

Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A “Real-Life” Observational Study in the First Year of Treatment

M. Bonini, G. Paludetti, J. Galli, 2022, Journal of clinical medicine.

Real-Life Experience in the Management of Sinonasal Complications of Dental Disease or Treatments

G. Paludetti, J. Galli, M. Rigante, 2022, Journal of personalized medicine.

Is There Any Reliable Predictor of Functional Recovery Following Post-thyroidectomy Vocal Fold Paralysis?

M. Raffaelli, M. Marchese, L. D’Alatri, 2022, World Journal of Surgery.

Evaluation of switching or simultaneous use of biologic treatment in patients with severe chronic rhinosinusitis with nasal polyps and severe asthma. Considerations in clinical decision making

M. Bonini, E. de Corso, J. Hagemann, 2023, Expert review of clinical immunology.

How to manage recurrences after surgery in CRSwNP patients in the biologic era: a narrative review

G. Paludetti, J. Galli, M. Rigante, 2023, Acta Otorhinolaryngologica Italica.

Measuring Nasal Patency and the Sense of Smell in CRSwNP Patients Treated with Dupilumab

E. Cantone, E. de Corso, G. Ottaviano, 2023, Journal of personalized medicine.

Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric observational phase 4 real-life study (DUPIREAL).

G. Paludetti, J. Galli, F. Bussu, 2023, Allergy. European Journal of Allergy and Clinical Immunology.